Delivery Order SPE2DB20D1109-SPE2DB22FN81M
Award Date
3/16/22
Potential Completion Date
3/17/22
Potential Value
$2.5K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,317.92, is for the delivery of CATHFLO ACTIVASE 2 MG VIALS, a medical product. This is a firm fixed-price delivery order contract with an ultimate completion date of December 27, 2024. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is...
This federal contract award, with ID SPE2DB22D3301|SPE2DB25FX4CM, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract, valued at $3,212.70, is a delivery order for the supply of 4,566,174,150 units of CATHFLO ACTIVASE 2 MG VIALS. This contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical...
This federal contract award, valued at $2,141.80, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of CATHFLO ACTIVASE 2 MG VIALS, a critical medical product, with a performance period through October 2024. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,188.23 firm fixed-price delivery order is for the supply of CATHFLO ACTIVASE 2 MG VIALS, a medical product. This contract award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which serves as a primary vehicle...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,131.20 firm-fixed price delivery order is for the supply of CATHFLO ACTIVASE 2 MG VIALS, a specialty medication. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award, SPE2DB22D1106|SPE2DB25FDJP3, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $3,212.70 firm fixed-price delivery order is for the supply of 4566293159 CATHFLO ACTIVASE 2 MG VIALS. The contract has an ultimate completion date of November 1, 2024 and was awarded on October 31, 2024. There is no set-aside designation specified. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,954,863 units of the pharmaceutical product CATHFLO ACTIVASE 2 MG VIALS. The contract has a ceiling value of $5,140.33 and a performance period through March 14, 2024. This delivery order contract is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen...
This federal contract award, with a ceiling value of $3,353.30, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of CATHFLO ACTIVASE 2 MG VIALS, a pharmaceutical product, with a period of performance through July 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $1,285.08 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4564204352 ! CATHFLO ACTIVASE 2 MG VIALS. This order is part of an indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for...
This federal contract award, with ID SPE2DB20D3101|SPE2DB25FRAL1, was granted by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,656.00 Firm Fixed Price Delivery Order contract is for the supply of CATHFLO ACTIVASE 2 MG VIALS, a medical product, with a period of performance ending on January 31, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...